Cargando…
Long‐term risk of a fatty liver in liver donors
AIM: Approximately 30 years have passed since the first experience of living donor liver transplantation. The time to evaluate the long‐term safety of living donors has been fulfilled. Meanwhile, nonalcoholic fatty liver disease is increasingly common and a critical problem. The aim of this study wa...
Autores principales: | Goto, Ryoichi, Kawamura, Norio, Watanabe, Masaaki, Ganchiku, Yoshikazu, Nagatsu, Akihisa, Okada, Kazufumi, Ito, Yoichi M., Kamiyama, Toshiya, Shimamura, Tsuyoshi, Taketomi, Akinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319612/ https://www.ncbi.nlm.nih.gov/pubmed/37416731 http://dx.doi.org/10.1002/ags3.12658 |
Ejemplares similares
-
The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
por: Goto, Ryoichi, et al.
Publicado: (2022) -
Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver
por: Fujii, Yuki, et al.
Publicado: (2020) -
Living Donor Liver Transplantation for Hepatic Venoocclusive Disease/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell Transplantation
por: Ichimura, Kentaro, et al.
Publicado: (2022) -
Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
por: Goto, Ryoichi, et al.
Publicado: (2023) -
Petersen’s hernia after living donor liver transplantation
por: Sakamoto, Sodai, et al.
Publicado: (2017)